HALE DAVID F 4
4 · Oncternal Therapeutics, Inc. · Filed Jun 30, 2023
Insider Transaction Report
Form 4
HALE DAVID F
Director
Transactions
- Award
Stock Options
2023-06-28+37,500→ 37,500 totalExercise: $0.36Exp: 2033-06-28→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.